| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC3484 |
| Trial ID | NCT05911217 |
| Disease | Pancreatic Cancer |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT041 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer |
| Year | 2023 |
| Country | China |
| Company sponsor | CARsgen Therapeutics Co., Ltd. |
| Other ID(s) | CT041-ST-05 |
| Cohort 1 | |||||||||
|
|||||||||